Adelaida Morte

1.4k total citations
27 papers, 1.1k citations indexed

About

Adelaida Morte is a scholar working on Small Animals, Pharmacology and Surgery. According to data from OpenAlex, Adelaida Morte has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Small Animals, 8 papers in Pharmacology and 7 papers in Surgery. Recurrent topics in Adelaida Morte's work include Veterinary Pharmacology and Anesthesia (8 papers), Anesthesia and Pain Management (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Adelaida Morte is often cited by papers focused on Veterinary Pharmacology and Anesthesia (8 papers), Anesthesia and Pain Management (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Adelaida Morte collaborates with scholars based in Spain, United Kingdom and United States. Adelaida Morte's co-authors include Manel J. Barbanoj, Jordi Riba, Gloria Urbano, Antoni Rodrı́guez-Fornells, Marta Valle, Mercedes Yritia, Rosa María Antonijoan, J. C. Callaway, María Jesús Miranda Montero and F Jané and has published in prestigious journals such as Journal of Neuroscience, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Adelaida Morte

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adelaida Morte Spain 14 556 281 249 210 206 27 1.1k
Luca Posa Canada 12 290 0.5× 401 1.4× 63 0.3× 281 1.3× 110 0.5× 23 834
F Jané Spain 18 265 0.5× 326 1.2× 107 0.4× 182 0.9× 106 0.5× 67 1.0k
Theo Huber Switzerland 8 821 1.5× 558 2.0× 98 0.4× 252 1.2× 293 1.4× 8 1.3k
R. Andrew Sewell United States 22 546 1.0× 727 2.6× 55 0.2× 752 3.6× 256 1.2× 36 1.8k
Antonio Inserra Canada 14 437 0.8× 311 1.1× 100 0.4× 119 0.6× 56 0.3× 30 1.2k
Martha López-Canul Canada 11 181 0.3× 330 1.2× 45 0.2× 282 1.3× 150 0.7× 19 783
R R Griffiths United States 19 254 0.5× 395 1.4× 69 0.3× 405 1.9× 167 0.8× 26 1.3k
Filip Tylš Czechia 12 403 0.7× 399 1.4× 52 0.2× 238 1.1× 110 0.5× 27 742
Jane Gosden United Kingdom 15 209 0.4× 460 1.6× 38 0.2× 256 1.2× 143 0.7× 29 1.0k
Luke A. Jelen United Kingdom 12 271 0.5× 253 0.9× 31 0.1× 252 1.2× 92 0.4× 23 691

Countries citing papers authored by Adelaida Morte

Since Specialization
Citations

This map shows the geographic impact of Adelaida Morte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adelaida Morte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adelaida Morte more than expected).

Fields of papers citing papers by Adelaida Morte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adelaida Morte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adelaida Morte. The network helps show where Adelaida Morte may publish in the future.

Co-authorship network of co-authors of Adelaida Morte

This figure shows the co-authorship network connecting the top 25 collaborators of Adelaida Morte. A scholar is included among the top collaborators of Adelaida Morte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adelaida Morte. Adelaida Morte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Viscusi, Eugene R., R. M. Langford, Adelaida Morte, et al.. (2024). Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials. Pain and Therapy. 13(6). 1617–1631.
3.
4.
Langford, R. M., et al.. (2024). Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain. Current Medical Research and Opinion. 40(3). 455–468. 9 indexed citations
5.
Langford, R. M., Esther Pogatzki‐Zahn, Adelaida Morte, et al.. (2024). Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1). Advances in Therapy. 41(3). 1025–1045. 8 indexed citations
6.
Langford, R. M., Adelaida Morte, Mariano Sust, et al.. (2022). Efficacy and safety of co‐crystal of tramadol‐celecoxib (CTC) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial (STARDOM2). European Journal of Pain. 26(10). 2083–2096. 13 indexed citations
7.
Morte, Adelaida, et al.. (2022). Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 47(4). 567–578. 6 indexed citations
8.
9.
Carlson, James D., Gregorio Encina, Mariano Sust, et al.. (2021). Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study. Clinical Therapeutics. 43(6). 1051–1065. 27 indexed citations
10.
Ghosh, Arunabha, Elsa Shapiro, Stewart Rust, et al.. (2017). Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III. Orphanet Journal of Rare Diseases. 12(1). 117–117. 23 indexed citations
11.
Romero, Sergio, Miguel Ángel Mañanas, Jordi Riba, et al.. (2005). Evaluation of an automatic ocular filtering method for awake spontaneous EEG signals based on independent component analysis. PubMed. 3. 925–928. 12 indexed citations
12.
Barbanoj, M.J., S. Clos, Sergio Romero, et al.. (2005). Sleep Laboratory Study on Single and Repeated Dose Effects of Paroxetine, Alprazolam and Their Combination in Healthy Young Volunteers. Neuropsychobiology. 51(3). 134–147. 17 indexed citations
13.
Riba, Jordi, Antoni Rodrı́guez-Fornells, Adelaida Morte, Thomas F. Münte, & Manel J. Barbanoj. (2005). Noradrenergic Stimulation Enhances Human Action Monitoring. Journal of Neuroscience. 25(17). 4370–4374. 75 indexed citations
14.
Morte, Adelaida, et al.. (2005). Effects of Tobacco Smoking on the Kinetics of the Pupillary Light Reflex: A Comparison between Smokers and Non-Smokers. Neuropsychobiology. 52(4). 169–175. 5 indexed citations
15.
Luque, A., et al.. (2004). Lack of Pharmacologic Interaction Between Paroxetine and Alprazolam at Steady State in Healthy Volunteers. Journal of Clinical Psychopharmacology. 24(3). 268–276. 17 indexed citations
16.
17.
Riba, Jordi, Marta Valle, Gloria Urbano, et al.. (2003). Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics. 306(1). 73–83. 285 indexed citations
18.
Riba, Jordi, Antoni Rodrı́guez-Fornells, Gloria Urbano, et al.. (2001). Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology. 154(1). 85–95. 222 indexed citations
19.
Morte, Adelaida, Josep M. Grinyó, R. Solà, et al.. (1999). Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Clinical Pharmacology & Therapeutics. 66(5). 485–491. 22 indexed citations
20.
Barbanoj, M.J., et al.. (1997). NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL. Pharmacological Research. 36(1). 41–47. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Posa Breakdown of academic impact, for papers by F Jané Breakdown of academic impact, for papers by Theo Huber Breakdown of academic impact, for papers by R. Andrew Sewell Breakdown of academic impact, for papers by Antonio Inserra Breakdown of academic impact, for papers by Martha López-Canul Breakdown of academic impact, for papers by R R Griffiths Breakdown of academic impact, for papers by Filip Tylš Breakdown of academic impact, for papers by Jane Gosden Breakdown of academic impact, for papers by Luke A. Jelen
Rankless by CCL
2026